{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:54:53Z","timestamp":1795121693848,"version":"4.10.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Doxorubicin (DOX) is an effective anthracycline chemotherapeutic anticancer drug with its life-threatening cardiotoxicity severely limiting its clinical application. Mitochondrial damage-induced cardiomyocyte death is considered an essential cue for DOX cardiotoxicity. FUN14 domain containing 1 (FUNDC1) is a mitochondrial membrane protein participating in the regulation of mitochondrial integrity in multiple diseases although its role in DOX cardiomyopathy remains elusive. Here, we examined whether PANoptosis, a novel type of programmed cell death closely associated with mitochondrial damage, was involved in DOX-induced heart injury, and FUNDC1-mediated regulation of cardiomyocyte PANoptosis, if any. FUNDC1 was downregulated in heart tissues in patients with dilated cardiomyopathy (DCM) and DOX-challenged mice. FUNDC1 deficiency aggravated DOX-induced cardiac dysfunction, mitochondrial injury, and cardiomyocyte PANoptosis. Further examination revealed that FUNDC1 countered cytoplasmic release of mitochondrial DNA (mtDNA) and activation of PANoptosome through interaction with mitochondrial Tu translation elongation factor (TUFM), a key factor in the translational expression and repair of mitochondrial DNA, via its 96\u2013133 amino acid domain. TUFM intervention reversed FUNDC1-elicited protection against DOX-induced mtDNA cytosolic release and cardiomyocyte PANoptosis. Our findings shed light toward a beneficial role of FUNDC1 in DOX cardiotoxicity and cardiomyocyte PANoptosis, thus offering therapeutic promises in DOX-induced cardiotoxicity.<\/jats:p>","DOI":"10.1038\/s41419-022-05460-x","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T12:03:08Z","timestamp":1670241788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM"],"prefix":"10.1038","volume":"13","author":[{"given":"Yaguang","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-7472","authenticated-orcid":false,"given":"Haixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9360-7332","authenticated-orcid":false,"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-0783","authenticated-orcid":false,"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"5460_CR1","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1096\/fj.201802663R","volume":"33","author":"MP Catanzaro","year":"2019","unstructured":"Catanzaro MP, Weiner A, Kaminaris A, Li C, Cai F, Zhao F, et al. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy. FASEB J. 2019;33:11096\u2013108.","journal-title":"FASEB J"},{"key":"5460_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell R. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2011;7:214\u201320.","journal-title":"Curr Cardiol Rev"},{"key":"5460_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021;12:339.","journal-title":"Cell Death Dis"},{"key":"5460_CR4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18:1639\u201342.","journal-title":"Nat Med"},{"key":"5460_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/CIRCULATIONAHA.117.030352","volume":"138","author":"M Li","year":"2018","unstructured":"Li M, Sala V, De Santis MC, Cimino J, Cappello P, Pianca N, et al. Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth. Circulation. 2018;138:696\u2013711.","journal-title":"Circulation."},{"key":"5460_CR6","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1111\/febs.15583","volume":"288","author":"SY van der Zanden","year":"2021","unstructured":"van der Zanden SY, Qiao X, Neefjes J. New insights into the activities and toxicities of the old anticancer drug doxorubicin. FEBS J. 2021;288:6095\u2013111.","journal-title":"FEBS J."},{"key":"5460_CR7","doi-asserted-by":"publisher","first-page":"732554","DOI":"10.3389\/fcvm.2021.732554","volume":"8","author":"W Yun","year":"2021","unstructured":"Yun W, Qian L, Yuan R, Xu H. Periplocymarin alleviates doxorubicin-induced heart failure and excessive accumulation of ceramides. Front Cardiovasc Med. 2021;8:732554.","journal-title":"Front Cardiovasc Med"},{"key":"5460_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","volume":"22","author":"M Sheibani","year":"2022","unstructured":"Sheibani M, Azizi Y, Shayan M, Nezamoleslami S, Eslami F, Farjoo MH, et al. Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches. Cardiovasc Toxicol. 2022;22:292\u201310.","journal-title":"Cardiovasc Toxicol"},{"key":"5460_CR9","doi-asserted-by":"publisher","first-page":"752","DOI":"10.21037\/cdt-19-707","volume":"10","author":"W Yu","year":"2020","unstructured":"Yu W, Qin X, Zhang Y, Qiu P, Wang L, Zha W, et al. Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K\/Akt\/mTOR-dependent manner. Cardiovasc Diagn Ther. 2020;10:752\u201369.","journal-title":"Cardiovasc Diagn Ther"},{"key":"5460_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbadis.2015.12.014","volume":"1862","author":"W Ge","year":"2016","unstructured":"Ge W, Yuan M, Ceylan AF, Wang X, Ren J. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Biochim Biophys Acta. 2016;1862:622\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"5460_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","volume":"34","author":"FS Carvalho","year":"2014","unstructured":"Carvalho FS, Burgeiro A, Garcia R, Moreno AJ, Carvalho RA, Oliveira PJ. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. 2014;34:106\u201335.","journal-title":"Med Res Rev"},{"key":"5460_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10004-6","volume":"12","author":"FJ Detmer","year":"2022","unstructured":"Detmer FJ, Alpert NM, Moon S-H, Dhaynaut M, Guerrero JL, Guehl NJ, et al. PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study. Sci Rep. 2022;12:6122.","journal-title":"Sci Rep."},{"key":"5460_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.taap.2019.02.016","volume":"369","author":"J Du","year":"2019","unstructured":"Du J, Hang P, Pan Y, Feng B, Zheng Y, Chen T, et al. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1\u03b1\/Drp1 pathway. Toxicol Appl Pharm. 2019;369:73\u201381.","journal-title":"Toxicol Appl Pharm"},{"key":"5460_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1787-7","volume":"10","author":"W Cai","year":"2019","unstructured":"Cai W, Fujita T, Hidaka Y, Jin H, Suita K, Shigeta M, et al. Translationally controlled tumor protein (TCTP) plays a pivotal role in cardiomyocyte survival through a Bnip3-dependent mechanism. Cell Death Dis. 2019;10:549.","journal-title":"Cell Death Dis"},{"key":"5460_CR15","doi-asserted-by":"crossref","unstructured":"Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020;5:e132747.","DOI":"10.1172\/jci.insight.132747"},{"key":"5460_CR16","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019;116:2672\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5460_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/cvr\/cvz240","volume":"116","author":"R Dhingra","year":"2020","unstructured":"Dhingra R, Guberman M, Rabinovich-Nikitin I, Gerstein J, Margulets V, Gang H, et al. Impaired NF-\u03baB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy. Cardiovasc Res. 2020;116:1161\u201374.","journal-title":"Cardiovasc Res"},{"key":"5460_CR18","doi-asserted-by":"publisher","first-page":"E5537","DOI":"10.1073\/pnas.1414665111","volume":"111","author":"R Dhingra","year":"2014","unstructured":"Dhingra R, Margulets V, Chowdhury SR, Thliveris J, Jassal D, Fernyhough P, et al. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling. Proc Natl Acad Sci USA. 2014;111:E5537\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5460_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb2422","volume":"14","author":"L Liu","year":"2012","unstructured":"Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012;14:177\u201385.","journal-title":"Nat Cell Biol"},{"key":"5460_CR20","doi-asserted-by":"publisher","first-page":"114891","DOI":"10.1016\/j.bcp.2021.114891","volume":"197","author":"H Liu","year":"2022","unstructured":"Liu H, Zang C, Yuan F, Ju C, Shang M, Ning J, et al. The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases. Biochemical Pharmacol. 2022;197:114891.","journal-title":"Biochemical Pharmacol"},{"key":"5460_CR21","doi-asserted-by":"crossref","unstructured":"Ren J, Sun M, Zhou H, Ajoolabady A, Zhou Y, Tao J, et al. FUNDC1 interacts with FBXL2 to govern mitochondrial integrity and cardiac function through an IP3R3-dependent manner in obesity. Sci Adv. 2020;6:eabc8561.","DOI":"10.1126\/sciadv.abc8561"},{"key":"5460_CR22","doi-asserted-by":"crossref","unstructured":"Li J, Agarwal E, Bertolini I, Seo JH, Caino MC, Ghosh JC, et al. The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells. Sci Signal. 2020;13:eaaz8240.","DOI":"10.1126\/scisignal.aaz8240"},{"key":"5460_CR23","doi-asserted-by":"publisher","first-page":"154840","DOI":"10.1016\/j.metabol.2021.154840","volume":"122","author":"Z Pei","year":"2021","unstructured":"Pei Z, Liu Y, Liu S, Jin W, Luo Y, Sun M, et al. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis. Metabolism. 2021;122:154840.","journal-title":"Metabolism."},{"key":"5460_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22771-3","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Dai X, Wu S, Xu W, Song P, Huang K. FUNDC1-dependent mitochondria-associated endoplasmic reticulum membranes are involved in angiogenesis and neoangiogenesis. Nat Commun. 2021;12:2616.","journal-title":"Nat Commun"},{"key":"5460_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imr.12909","volume":"297","author":"M Zheng","year":"2020","unstructured":"Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297:26\u201338.","journal-title":"Immunol Rev"},{"key":"5460_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","volume":"9","author":"RKS Malireddi","year":"2019","unstructured":"Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406.","journal-title":"Front Cell Infect Microbiol"},{"key":"5460_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fcimb.2020.00238","volume":"10","author":"P Samir","year":"2020","unstructured":"Samir P, Malireddi RKS, Kanneganti TD. The PANoptosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:238.","journal-title":"Front Cell Infect Microbiol"},{"key":"5460_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","volume":"181","author":"M Zheng","year":"2020","unstructured":"Zheng M, Karki R, Vogel P, Kanneganti TD. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell. 2020;181:674\u201387.e13.","journal-title":"Cell."},{"key":"5460_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fcimb.2020.00237","volume":"10","author":"S Christgen","year":"2020","unstructured":"Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:237.","journal-title":"Front Cell Infect Microbiol"},{"key":"5460_CR30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.4049\/immunohorizons.2000097","volume":"4","author":"RKS Malireddi","year":"2020","unstructured":"Malireddi RKS, Kesavardhana S, Karki R, Kancharana B, Burton AR, Kanneganti TD. RIPK1 distinctly regulates yersinia-induced inflammatory cell death, PANoptosis. Immunohorizons. 2020;4:789\u201396.","journal-title":"Immunohorizons."},{"key":"5460_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597:415\u20139.","journal-title":"Nature."},{"key":"5460_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04664-5","volume":"13","author":"Y Messaoud-Nacer","year":"2022","unstructured":"Messaoud-Nacer Y, Culerier E, Rose S, Maillet I, Rouxel N, Briault S, et al. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). Cell Death Dis. 2022;13:269.","journal-title":"Cell Death Dis"},{"key":"5460_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.cell.2017.09.029","volume":"171","author":"EV Dang","year":"2017","unstructured":"Dang EV, McDonald JG, Russell DW, Cyster JG. Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation. Cell. 2017;171:1057\u201371.e11.","journal-title":"Cell."},{"key":"5460_CR34","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00018-015-2122-9","volume":"73","author":"K He","year":"2016","unstructured":"He K, Guo X, Liu Y, Li J, Hu Y, Wang D, et al. TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3\u03b2 signaling. Cell Mol Life Sci. 2016;73:2105\u201321.","journal-title":"Cell Mol Life Sci"},{"key":"5460_CR35","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1093\/nar\/gkv472","volume":"43","author":"J Liu","year":"2015","unstructured":"Liu J, Fang H, Chi Z, Wu Z, Wei D, Mo D, et al. XPD localizes in mitochondria and protects the mitochondrial genome from oxidative DNA damage. Nucleic Acids Res. 2015;43:5476\u201388.","journal-title":"Nucleic Acids Res"},{"key":"5460_CR36","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1182\/blood-2016-10-741207","volume":"129","author":"SU Liyanage","year":"2017","unstructured":"Liyanage SU, Hurren R, Voisin V, Bridon G, Wang X, Xu C, et al. Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML. Blood. 2017;129:2657\u201366.","journal-title":"Blood."},{"key":"5460_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149\u201368.e17.","journal-title":"Cell."},{"key":"5460_CR38","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Kanneganti TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641\u201357.","journal-title":"Comput Struct Biotechnol J."},{"key":"5460_CR39","doi-asserted-by":"publisher","first-page":"960327121106606","DOI":"10.1177\/09603271211066066","volume":"41","author":"Z Erdogmus Ozgen","year":"2022","unstructured":"Erdogmus Ozgen Z, Erdinc M, Kelle \u0130, Erdinc L, Nergiz Y. Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart. Hum Exp Toxicol. 2022;41:9603271211066066.","journal-title":"Hum Exp Toxicol"},{"key":"5460_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1901-x","volume":"10","author":"JA Pan","year":"2019","unstructured":"Pan JA, Tang Y, Yu JY, Zhang H, Zhang JF, Wang CQ, et al. miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2019;10:668.","journal-title":"Cell Death Dis"},{"key":"5460_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2018.08.032","volume":"129","author":"D Liu","year":"2018","unstructured":"Liu D, Ma Z, Di S, Yang Y, Yang J, Xu L, et al. AMPK\/PGC1\u03b1 activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radic Biol Med. 2018;129:59\u201372.","journal-title":"Free Radic Biol Med"},{"key":"5460_CR42","doi-asserted-by":"publisher","first-page":"152881","DOI":"10.1016\/j.tox.2021.152881","volume":"460","author":"C Wang","year":"2021","unstructured":"Wang C, Hu L, Guo S, Yao Q, Liu X, Zhang B, et al. Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro. Toxicology. 2021;460:152881.","journal-title":"Toxicology"},{"key":"5460_CR43","doi-asserted-by":"publisher","first-page":"109858","DOI":"10.1016\/j.celrep.2021.109858","volume":"37","author":"R Karki","year":"2021","unstructured":"Karki R, Sundaram B, Sharma BR, Lee S, Malireddi RKS, Nguyen LN, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021;37:109858.","journal-title":"Cell Rep."},{"key":"5460_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.bbrc.2018.10.003","volume":"505","author":"HK Kim","year":"2018","unstructured":"Kim HK, Kang YG, Jeong SH, Park N, Marquez J, Ko KS, et al. Cyclic stretch increases mitochondrial biogenesis in a cardiac cell line. Biochem Biophys Res Commun. 2018;505:768\u201374.","journal-title":"Biochem Biophys Res Commun"},{"key":"5460_CR45","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molcel.2020.10.007","volume":"80","author":"J Lin","year":"2020","unstructured":"Lin J, Chen K, Chen W, Yao Y, Ni S, Ye M, et al. Paradoxical mitophagy regulation by PINK1 and TUFm. Mol Cell. 2020;80:607\u201320.e12.","journal-title":"Mol Cell"},{"key":"5460_CR46","first-page":"8192552","volume":"2022","author":"Q Li","year":"2022","unstructured":"Li Q, Liu Y, Huang Q, Yi X, Qin F, Zhong Z, et al. Hypoxia acclimation protects against heart failure postacute myocardial infarction via Fundc1-mediated mitophagy. Oxid Med Cell Longev. 2022;2022:8192552.","journal-title":"Oxid Med Cell Longev"},{"key":"5460_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02805-2","volume":"11","author":"W Li","year":"2020","unstructured":"Li W, Yin L, Sun X, Wu J, Dong Z, Hu K, et al. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell Death Dis. 2020;11:599.","journal-title":"Cell Death Dis"},{"key":"5460_CR48","doi-asserted-by":"publisher","first-page":"887045","DOI":"10.3389\/fphar.2022.887045","volume":"13","author":"Y Mao","year":"2022","unstructured":"Mao Y, Ren J, Yang L. FUN14 domain containing 1 (FUNDC1): a promising mitophagy receptor regulating mitochondrial homeostasis in cardiovascular diseases. Front Pharm. 2022;13:887045.","journal-title":"Front Pharm"},{"key":"5460_CR49","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1080\/15548627.2019.1596482","volume":"15","author":"H Wu","year":"2019","unstructured":"Wu H, Wang Y, Li W, Chen H, Du L, Liu D, et al. Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome. Autophagy. 2019;15:1882\u201398.","journal-title":"Autophagy."},{"key":"5460_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41392-019-0094-1","volume":"4","author":"H Zhou","year":"2019","unstructured":"Zhou H, Zhu P, Wang J, Toan S, Ren J. DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy. Signal Transduct Target Ther. 2019;4:56.","journal-title":"Signal Transduct Target Ther"},{"key":"5460_CR51","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/hep.30191","volume":"69","author":"W Li","year":"2019","unstructured":"Li W, Li Y, Siraj S, Jin H, Fan Y, Yang X, et al. FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice. Hepatology. 2019;69:604\u201321.","journal-title":"Hepatology."},{"key":"5460_CR52","doi-asserted-by":"crossref","unstructured":"Yu W, Chen C, Xu C, Xie D, Wang Q, Liu W, et al. Activation of p62-NRF2 Axis protects against doxorubicin-induced ferroptosis in cardiomyocytes: a novel role and molecular mechanism of resveratrol. Am J Chin Med. 2022;50:2103\u201323.","DOI":"10.1142\/S0192415X22500902"},{"key":"5460_CR53","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-S\u00e1nchez R, Reinal I, Peir\u00f3-Molina E, Buigues M, Tejedor S, Hern\u00e1ndiz A, et al. MicroRNA-4732-3p is dysregulated in breast cancer patients with cardiotoxicity, and its therapeutic delivery protects the heart from doxorubicin-induced oxidative stress in rats. Antioxidants. 2022;11:1955.","DOI":"10.3390\/antiox11101955"},{"key":"5460_CR54","doi-asserted-by":"publisher","first-page":"960327122113620","DOI":"10.1177\/09603271221136209","volume":"41","author":"MMM Refaie","year":"2022","unstructured":"Refaie MMM, El-Hussieny M, Abdel-Hakeem EA, Fawzy MA, Mahmoud Abd El Rahman ES, Shehata S. Phosphodiesterase inhibitor, Vinpocetine, guards against doxorubicin induced cardiotoxicity via modulation of HIF\/VEGF and cGMP\/cAMP\/SIRT signaling pathways. Hum Exp Toxicol. 2022;41:9603271221136209.","journal-title":"Hum Exp Toxicol"},{"key":"5460_CR55","doi-asserted-by":"crossref","unstructured":"Podyacheva E, Semenova N, Zinserling V, Mukhametdinova D, Goncharova I, Zelinskaya I, et al. Intravenous nicotinamide riboside administration has a cardioprotective effect in chronic doxorubicin-induced cardiomyopathy. Int J Mol Sci. 2022;23:13096.","DOI":"10.3390\/ijms232113096"},{"key":"5460_CR56","doi-asserted-by":"publisher","first-page":"101553","DOI":"10.1016\/j.molmet.2022.101553","volume":"64","author":"C Cai","year":"2022","unstructured":"Cai C, Wu F, Zhuang B, Ou Q, Peng X, Shi N, et al. Empagliflozin activates Wnt\/\u03b2-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome. Mol Metab. 2022;64:101553.","journal-title":"Mol Metab"},{"key":"5460_CR57","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.phrs.2020.104846","volume":"157","author":"X Liang","year":"2020","unstructured":"Liang X, Wang S, Wang L, Ceylan AF, Ren J, Zhang Y. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission. Pharmacol Res. 2020;157:104846.","journal-title":"Pharmacol Res"},{"key":"5460_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.yjmcc.2018.04.009","volume":"119","author":"S Wang","year":"2018","unstructured":"Wang S, Ge W, Harns C, Meng X, Zhang Y, Ren J. Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy. J Mol Cell Cardiol. 2018;119:40\u201350.","journal-title":"J Mol Cell Cardiol"},{"key":"5460_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fphys.2020.00113","volume":"11","author":"H Xu","year":"2020","unstructured":"Xu H, Yu W, Sun S, Li C, Zhang Y, Ren J. Luteolin attenuates doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy. Front Physiol. 2020;11:113.","journal-title":"Front Physiol"},{"key":"5460_CR60","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.7150\/thno.46883","volume":"10","author":"W Yu","year":"2020","unstructured":"Yu W, Sun S, Xu H, Li C, Ren J, Zhang Y. TBC1D15\/RAB7-regulated mitochondria-lysosome interaction confers cardioprotection against acute myocardial infarction-induced cardiac injury. Theranostics. 2020;10:11244\u201363.","journal-title":"Theranostics."},{"key":"5460_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2013.12.010","volume":"71","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Han X, Hu N, Huff AF, Gao F, Ren J. Akt2 knockout alleviates prolonged caloric restriction-induced change in cardiac contractile function through regulation of autophagy. J Mol Cell Cardiol. 2014;71:81\u201391.","journal-title":"J Mol Cell Cardiol"},{"key":"5460_CR62","doi-asserted-by":"publisher","first-page":"101415","DOI":"10.1016\/j.redox.2019.101415","volume":"30","author":"J Wang","year":"2020","unstructured":"Wang J, Zhu P, Li R, Ren J, Zhou H. Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission. Redox Biol. 2020;30:101415.","journal-title":"Redox Biol"},{"key":"5460_CR63","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/ATVBAHA.117.309017","volume":"37","author":"Y Mao","year":"2017","unstructured":"Mao Y, Luo W, Zhang L, Wu W, Yuan L, Xu H, et al. STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2017;37:920\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05460-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T12:03:15Z","timestamp":1670241795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05460-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5460"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05460-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1773973\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"19 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1020"}}